Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.75 |
| ▸ | MAPT | P10636 | 3/20 | 0.75 |
| ▸ | TP53 | P04637 | 2/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.75 |
| ▸ | HPGD | P15428 | 2/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.74 |
| ▸ | AR | P10275 | 2/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | PPARG | P37231 | 1/20 | 0.73 |
| ▸ | CCNC | P24863 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chrysin Dimethyl Ether SCHEMBL1676012 | 1.00 | ABCG2 (1.00) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL31238392 | 0.91 | KDM4E (0.83) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| Trimethylapigenin SCHEMBL29350875 | 0.90 | ABCB1 (1.00) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| Trimethylapigenin SCHEMBL1421585 | 0.90 | ABCB1 (1.00) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL20100898 | 0.87 | KDM4E (0.78) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL4051739 | 0.87 | KDM4E (0.78) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL4165061 | 0.87 | ABCB1 (0.81) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL19235588 | 0.86 | ALDH1A1 (0.76) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL17193739 | 0.86 | ABCB1 (0.87) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL13945269 | 0.86 | ABCB1 (0.78) | ABCG2ALDH1A1KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3500283-B1 | A FORMULATION FOR IMPROVING PHYSICAL ENDURANCE IN ATHLETES AND A METHOD FOR PREPARING THE SAME | AUREA BIOLABS PRIVATE LTD (IN) | 2026-02-18 | — | — | EP | claimed |
| CN-111971042-B | Granulin for identifying as causative agent of Alzheimer's disease, composition and method for inhibiting aggregation of granulin and treating Alzheimer's disease | 刘承铉 | 2024-01-02 | — | — | CN | claimed |
| CN-122029153-A | Aromatic hydrocarbon receptor modulator compound, and preparation method and application thereof | 德明药泰生物技术（深圳）有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-121816180-A | Preparation of penis erection gel and its preparing process | MD产品&服务有限公司 | 2026-04-07 | — | — | CN | disclosed |
| US-12590094-B2 | Compounds for the treatment of neurodegenerative and metabolic disorders | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-03-31 | — | — | US | disclosed |
| CN-121577766-A | Method, system and application for detecting adulteration in vegetable oil | 长沙市食品药品检验所 | 2026-02-27 | — | — | CN | disclosed |
| EP-3500283-B1 | A FORMULATION FOR IMPROVING PHYSICAL ENDURANCE IN ATHLETES AND A METHOD FOR PREPARING THE SAME | AUREA BIOLABS PRIVATE LTD (IN) | 2026-02-18 | — | — | EP | disclosed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-118995656-A | Demethylation functional enzyme of flavonoid compound, and encoding gene and application thereof | 上海中医药大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-116035988-B | Anti-dandruff and anti-drop ginger-like composition, and preparation method and application thereof | 泉后(广州)生物科技研究院有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-118415234-A | Myotonin oxidation-resistant nano film based on Maillard reaction and preparation method and application thereof | 沈阳农业大学 | 2024-08-02 | — | — | CN | disclosed |
| CN-114867486-B | Composition containing black ginger extract and composition for oral administration | 丸善制药株式会社 | 2023-05-30 | — | — | CN | disclosed |
| CN-116114778-A | Food composition for promoting testosterone level and preparation method thereof | 广州正广生物科技有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-116035988-A | Anti-dandruff and anti-drop ginger-like composition, and preparation method and application thereof | 泉后(广州)生物科技研究院有限公司 | 2023-05-02 | — | — | CN | disclosed |
| US-20230041523-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE AND METABOLIC DISORDERS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2023-02-09 | — | — | US | disclosed |
| CN-113694155-B | Kaempferia galanga total flavone extract and preparation method and application thereof | 清华大学 | 2022-10-18 | — | — | CN | disclosed |
| CN-114867486-A | Composition containing Heijiang extract and oral composition | 丸善制药株式会社 | 2022-08-05 | — | — | CN | disclosed |
| US-20220105072-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES COMPLICATIONS COMPRISING NOVEL CHRYSIN DERIVATIVE COMPOUND AS ACTIVE INGREDIENT | FRONTBIO INC (KR) | 2022-04-07 | — | — | US | disclosed |
| CN-114173797-A | Product infused with cannabis with enhanced cannabinoid profile user experience | 埃克索运营公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-114098065-A | Biological product for improving male functions and preparation method and application thereof | 张学记 | 2022-03-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220105072-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES COMPLICATIONS COMPRISING NOVEL CHRYSIN DERIVATIVE COMPOUND AS ACTIVE INGREDIENT | AGER, IAPP, GCG | ABCG2 1849/4885ALDH1A1 3899/4885KDM4E 3203/4885 |
| US-12590094-B2 | Compounds for the treatment of neurodegenerative and metabolic disorders | TXN2, SMN1; SMN2, SNCA | ABCG2 1792/4885ALDH1A1 237/4885KDM4E 4079/4885 |
| US-20230041523-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE AND METABOLIC DISORDERS | NLN, GLS, PRNP | ABCG2 2717/4885ALDH1A1 495/4885KDM4E 2500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.